Verheij M, Dewit L G, Valdés Olmos R A, Arisz L
Department of Radiotherapy, The Netherlands Cancer Institute (Antoni van Leeuwenhoek Huis), Amsterdam.
Int J Radiat Oncol Biol Phys. 1994 Oct 15;30(3):677-83. doi: 10.1016/0360-3016(92)90955-h.
This study was undertaken to investigate whether the hypertension observed in a subgroup of patients with progressive radiation-induced nephropathy has a renovascular component.
Fifteen patients with prospectively documented renal injury after high-dose radiation treatment for various abdominal malignancies were studied, 8 of them having hypertension. 99mTc-DTPA renography and plasma renin activity measurements were performed before and after an oral dose of 50 mg captopril. In patients with a positive captopril renography, a selective angiography was performed to exclude preexisting central renal artery stenosis and to assess the type and extent of the vascular changes.
The captopril 99mTc-DTPA renography demonstrated a longer time until maximal renal activity (Tmax) compared with the baseline study in five out of eight hypertensive patients. This increase in Tmax was observed in both high-dose (40 Gy/5.5 weeks) and in low-dose (12-13 Gy/3 weeks) irradiated kidneys. No increase in Tmax was observed in the normotensive patients. In the five hypertensive cases with an increased Tmax, selective angiography demonstrated severe stenotic and tortuous changes in the small intrarenal branches of the high-dose irradiated kidneys without stenosis of the main renal artery. Captopril induced an increase in peripheral plasma renin activity in the hypertensive group, but not in the normotensive patients.
These data suggest a radiation-induced hypertension, mediated by the renin-angiotensin system due to damage in predominantly small renal arteries. It was possible to demonstrate hypertensive changes with a captopril 99mTc-DTPA renography, even after presumed subthreshold radiation doses for clinical radiation nephropathy.
本研究旨在调查在一组进行性放射性肾病患者中观察到的高血压是否存在肾血管成分。
对15例因各种腹部恶性肿瘤接受高剂量放射治疗后有前瞻性记录的肾损伤患者进行了研究,其中8例患有高血压。在口服50毫克卡托普利前后进行了99mTc - DTPA肾图检查和血浆肾素活性测量。对于卡托普利肾图检查阳性的患者,进行选择性血管造影以排除先前存在的肾中央动脉狭窄,并评估血管变化的类型和程度。
与基线研究相比,8例高血压患者中有5例的卡托普利99mTc - DTPA肾图显示达到最大肾活性的时间(Tmax)更长。在高剂量(40 Gy/5.5周)和低剂量(12 - 13 Gy/3周)照射的肾脏中均观察到Tmax的这种增加。血压正常的患者未观察到Tmax增加。在Tmax增加的5例高血压病例中,选择性血管造影显示高剂量照射肾脏的肾内小分支有严重的狭窄和扭曲变化,而主肾动脉无狭窄。卡托普利使高血压组的外周血浆肾素活性增加,但血压正常的患者未增加。
这些数据表明存在由肾素 - 血管紧张素系统介导的放射性高血压,主要是由于小肾动脉受损所致。即使在推测低于临床放射性肾病阈值的放射剂量后,卡托普利99mTc - DTPA肾图也能够显示高血压变化。